search
Back to results

Quality of Life of Patients and Theirs Parents With Inherited Metabolic Diseases With Restricted Diet (MHMRSQol)

Primary Purpose

Inherited Metabolic Diseases Requiring Restrictive and Specific Diet

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
data assessment of the state of health and quality of life of patients and their families
Sponsored by
Assistance Publique Hopitaux De Marseille
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Inherited Metabolic Diseases Requiring Restrictive and Specific Diet

Eligibility Criteria

undefined - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Included in MHMRS databases from different centers

  • Age less than 18 years at diagnosis
  • Diagnostic MHMRS made from 01/01/2000
  • Treatment and management of MHMRS initiated in one of the clinical sites
  • Living in France

    • Living
    • Compliance with criteria for inclusion in the cohort
    • Having agreed to participate in the study
    • Allowed to participate in the study by the parents or legal guardians for any minor subject.

Exclusion Criteria:

  • Can't be included subjects not complying with at least one of the inclusion criteria previously mentioned .
  • Excludes all subjects at least one of the following criteria:

    • Moving outside France after baseline ( initial treatment performed in one of the participating centers )
    • Withdrawal of consent / refusal of monitoring;
    • Not responding at three successive waves of investigation.

Sites / Locations

  • Hôpital de la Timone Assistance Publique Hôpitaux de MarseilleRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

patients and their parents with inherited metabolic diseases

Arm Description

The population is a dynamic/open cohort consists of all patients MHMRS diagnosed and supported in one of the six Centers of Reference for Metabolical disease or one of the three Centers of Competence for Hereditary Metabolic Diseases or in the Center of Réference for Hereditary liver Metabolism Diseases since 2000. For each patient, the date of entry into the cohort is the diagnostic date of MHMRS. The study includes all prevalent and incident cases .

Outcomes

Primary Outcome Measures

Patient's anxiety assessment
Anxiety assessment of children by autoquestionnaires: STAI-C (8-10 years old); STAI-Y (11-17 years old); STAI (patients becoming adults)
Assessment of adaptive coping strategies of patients
Assessment of adaptive coping strategies of patients by questionnaires (BriefCope for adults patients, Kidcope for young patients)
Patient's behavior assessment
Assessment of child's behavior by Strengths and difficulties questionnaires and assessment of adult's behavior by the sociale adaptation scale (Weintraub scale)
Patient's quality of life assessment
Patient's quality of life assessment by VSP-A questionnaire
Parent's quality of life assessment
Parent's quality of life assessment by WHOQOL-BREF questionnaire
Assessment of adaptive coping strategies of parents
Assessment of adaptive coping strategies of parents by BriefCope questionnaire
Parent's anxiety assessment
Parent's anxiety assessment by STAI questionnaire

Secondary Outcome Measures

Full Information

First Posted
July 1, 2015
Last Updated
September 10, 2021
Sponsor
Assistance Publique Hopitaux De Marseille
search

1. Study Identification

Unique Protocol Identification Number
NCT02552784
Brief Title
Quality of Life of Patients and Theirs Parents With Inherited Metabolic Diseases With Restricted Diet
Acronym
MHMRSQol
Official Title
Determinants of Health Status and Quality of Life of Patients and Their Parents With Inherited Metabolic Diseases Diagnosed During Childhood and Requiring Restrictive and Specific Diet
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 2015 (undefined)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
December 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique Hopitaux De Marseille

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The general objective is study medical, socioeconomic, behavioral, health environmental, school and professional integration, and short- and medium- term quality of life determinants for all patients under 18 years old, residing in France for which the diagnosis of inherited metabolic diseases with specific regime (MHMRS) has been achieved during their childhood.
Detailed Description
The study population is a dynamic/open cohort consists of all patients MHMRS diagnosed and supported in one of the six Centers of Reference for Metabolical disease or one of the three Centers of Competence for Hereditary Metabolic Diseases or in the Center of Réference for Hereditary liver Metabolism Diseases since 2000. For each patient, the date of entry into the cohort is the diagnostic date of MHMRS. The study includes all prevalent and incident cases . The evaluations include all data collected by querying patients and their families and medical data collected by the medical team. The data collected concern in one hand explanatory variables characterizing the state of health and quality of life of patients, on the other variables describing the factors considered as potential determinants, namely: Socio -demographic and socio-economic on the patient and family. Clinical and therapeutic relative to the patient : age at the time of diagnosis, illness and consequences, type of treatment and diet. On possible alterations of physical health: overall assessment of the importance of using health professionals and specific description of the various physical health problems. Psycho- behavioral and cognitive. Quality of life of patients and their family. On the patient's relationship with the care system (access to care and satisfaction). The frequency of evaluations is 2 years. The evaluation will be at a consultation in the usual medical monitoring way up conducted in these children, allowing to collect clinical information directly nearby medical teams that support them. The various measurement tools used are: STAI-C and STAI-Y BRIEFCOPE and KIDCOPE GOODMAN questionnaire FAS questionnaire WECHSLER scale VSPA, VSPA-e and VSPA-p QUALIN WHOQOL-BREF The project is under the authority of a Steering Committee comprising representatives of all the partners in the project teams. The project is supervised by the Scientific Council of the SFEIM (Société Francaise pour les Erreurs Inées du Métabolisme) and the G2M (Groupement des centres de référence et de compétence des Maladies héréditaires du Métabolisme) which is consulted on the scientific guidance of the project. At the end of a study report will be prepared. It will detail all the decisions inherent in the conduct of the project and the results obtained. This report will be sent to the Ministry of Health under the cover of the Delegation for Clinical Research. The report will form the basis of the adjacent communications will be co-signed by the members of the Steering Committee and will reference the origin of the aid received.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inherited Metabolic Diseases Requiring Restrictive and Specific Diet

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
763 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
patients and their parents with inherited metabolic diseases
Arm Type
Experimental
Arm Description
The population is a dynamic/open cohort consists of all patients MHMRS diagnosed and supported in one of the six Centers of Reference for Metabolical disease or one of the three Centers of Competence for Hereditary Metabolic Diseases or in the Center of Réference for Hereditary liver Metabolism Diseases since 2000. For each patient, the date of entry into the cohort is the diagnostic date of MHMRS. The study includes all prevalent and incident cases .
Intervention Type
Behavioral
Intervention Name(s)
data assessment of the state of health and quality of life of patients and their families
Intervention Description
Study medical determinants, socioeconomic, behavioral, environmental of health, school and professional integration, and short- and medium-term quality of life of all patients residing in France for which the diagnosis of hereditary diseases metabolism with specific diet (MHMRS) was performed during their childhood.
Primary Outcome Measure Information:
Title
Patient's anxiety assessment
Description
Anxiety assessment of children by autoquestionnaires: STAI-C (8-10 years old); STAI-Y (11-17 years old); STAI (patients becoming adults)
Time Frame
6 years
Title
Assessment of adaptive coping strategies of patients
Description
Assessment of adaptive coping strategies of patients by questionnaires (BriefCope for adults patients, Kidcope for young patients)
Time Frame
6 years
Title
Patient's behavior assessment
Description
Assessment of child's behavior by Strengths and difficulties questionnaires and assessment of adult's behavior by the sociale adaptation scale (Weintraub scale)
Time Frame
6 years
Title
Patient's quality of life assessment
Description
Patient's quality of life assessment by VSP-A questionnaire
Time Frame
6 years
Title
Parent's quality of life assessment
Description
Parent's quality of life assessment by WHOQOL-BREF questionnaire
Time Frame
6 years
Title
Assessment of adaptive coping strategies of parents
Description
Assessment of adaptive coping strategies of parents by BriefCope questionnaire
Time Frame
6 years
Title
Parent's anxiety assessment
Description
Parent's anxiety assessment by STAI questionnaire
Time Frame
6 years

10. Eligibility

Sex
All
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Included in MHMRS databases from different centers Age less than 18 years at diagnosis Diagnostic MHMRS made from 01/01/2000 Treatment and management of MHMRS initiated in one of the clinical sites Living in France Living Compliance with criteria for inclusion in the cohort Having agreed to participate in the study Allowed to participate in the study by the parents or legal guardians for any minor subject. Exclusion Criteria: Can't be included subjects not complying with at least one of the inclusion criteria previously mentioned . Excludes all subjects at least one of the following criteria: Moving outside France after baseline ( initial treatment performed in one of the participating centers ) Withdrawal of consent / refusal of monitoring; Not responding at three successive waves of investigation.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Brigitte CHABROL
Phone
04 91 32 45 17
Email
brigitte.chabrol@ap-hm.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Urielle DESALBRES
Organizational Affiliation
Assistance Publique Hôpitaux de Marseille
Official's Role
Study Director
Facility Information:
Facility Name
Hôpital de la Timone Assistance Publique Hôpitaux de Marseille
City
Marseille
ZIP/Postal Code
13354
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brigitte CHABROL
Phone
04 91 32 45 17
Email
brigitte.chabrol@ap-hm.fr

12. IPD Sharing Statement

Learn more about this trial

Quality of Life of Patients and Theirs Parents With Inherited Metabolic Diseases With Restricted Diet

We'll reach out to this number within 24 hrs